Cantonal opioid agonist treatment authorisation systems – a mixed-method qualitative investigation
Swiss Medical Weekly · 2024
DOI: 10.57187/s.3629 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift Swiss Medical Weekly, 2024. Verfasst von Caroline Schmitt-Koopmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Analgesics, Opioid. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND AND AIM: In Switzerland, a cantonal authorisation is required to introduce opioid agonist treatments (OAT). We investigated and compared the terms of these cantonal OAT authorisations throughout Switzerland. The primary objective was to determine how the overseeing cantonal officials implemented and perceived the legal requirements. METHOD: We started with a cross-sectional analysis of legal texts and cantonal OAT guidelines. Based on the document analysis, we conducted 26 semi-structured interviews with the cantonal officials who grant OAT authorisations. FINDINGS: In most cantons (21 of 25), the OAT authorisation is specific to the person treated and must be renewed every year. Today, 21 cantons either have implemented or are implementing the same web-based software to process and manage OAT authorisation requests. Cantons have implemented diverging requirements regarding, amongst others, the involvement of third parties in OAT and the training required of prescribing physicians. Lastly, the OAT process does not seem to be a high priority for the overseeing officials. CONCLUSIONS: From a legal standpoint, OAT authorisations should be straightforward, yet we found significant divergences among cantonal systems. We could not find scientific evidence that supports a given framework. We recommend harmonizing the 26 cantonal systems while reviewing the need for OAT authorisation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
- Faculty of Business and Economics, University of Lausanne, Lausanne, Switzerland.
- Faculty of Law, University of Geneva, Geneva, Switzerland.
- Addiction Medicine, Geneva University Hospitals, Genève, Switzerland.
- Addiction Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Zitieren
APA
Schmitt-Koopmann, C., Baud, C. A., Beuriot, S., Junod, V., Broers, B., & Simon, O. (2024). Cantonal opioid agonist treatment authorisation systems – a mixed-method qualitative investigation. Swiss Medical Weekly. https://doi.org/10.57187/s.3629
Vancouver
Schmitt-Koopmann C, Baud CA, Beuriot S, Junod V, Broers B, Simon O. Cantonal opioid agonist treatment authorisation systems – a mixed-method qualitative investigation. Swiss Medical Weekly. 2024. doi:10.57187/s.3629
BibTeX
@article{SchmittKoopmann2024,
author = {Schmitt-Koopmann, Caroline and Baud, Carole-Anne and Beuriot, Stéphanie and Junod, Valérie and Broers, Barbara and Simon, Olivier},
title = {Cantonal opioid agonist treatment authorisation systems – a mixed-method qualitative investigation},
journal = {Swiss Medical Weekly},
year = {2024},
doi = {10.57187/s.3629}
}
EUVIMED